Chelation of Thallium (III) in Rats Using Combined Deferasirox and Deferiprone Therapy |
Salehi, Samie
(Department of Chemistry, Ferdowsi University of Mashhad, Faculty of Science)
Saljooghi, Amir Sh. (Department of Chemistry, Ferdowsi University of Mashhad, Faculty of Science) Badiee, Somayeh (Department of Chemistry, Ferdowsi University of Mashhad, Faculty of Science) Moqadam, Mojtaba Mashmool (Department of Chemistry, Ferdowsi University of Mashhad, Faculty of Science) |
1 | Heinz, U., Hegetschweiler, K., Acklin, P., Faller, B., Lattmann, R. and Schnebli, H.P. (1999) 4-[3,5-Bis (2-hydroxyphenyl)-1,2,4-triazol-1-yl]- benzoic acid: a novel, efficient and selective iron (III) complexing agent. Angew. Chem. Int. Ed., 38, 2568-2570. DOI |
2 | Steinhauser, S., Heinz, U., Bartholomä, M., Weyhermüller, T., Nick, H. and Hegetschweiler, K. (2004) Complex formation of ICL670 and related ligands with FeIII and FeII. Eur. J. Inorg. Chem., 2004, 4177-4192. |
3 | Yang, L.P.H., Keam, S.J. and Keating, G.M. (2007) Deferasirox: a review of its use in the management of transfusional chronic iron overload. Drugs, 67, 2211-2230. DOI |
4 | Kontoghiorghes, G.J. (1995) New concepts of iron and aluminium chelation therapy with oral L1 (deferiprone) and other chelators. A review. Analyst, 120, 845-851. DOI |
5 | Liu, Z.D. and Hider, R.C. (2002) Design of iron chelators with therapeutic application. Coord. Chem. Rev., 232, 151-171. DOI |
6 | Tenenbein, M. (2005) Unit-dose packaging of iron supplements and reduction of iron poisoning in young children. Arch. Pediatr. Adolesc. Med., 159, 557-560. DOI |
7 | Eom, S.Y., Lim, J.A., Kim, Y.D., Choi, B.S., Hwang, M.S., Park, J.D., Kim, H. and Kwon, H.J. (2016) Allele frequencies of the single nucleotide polymorphisms related to the body burden of heavy metals in the korean population and their ethnic differences. Toxicol. Res., 32, 195-205. DOI |
8 | Galanello, R., Agus, A., Campus, S., Danjou, F., Giardina, P.J. and Grady, R.W. (2010) Combined iron chelation therapy. Ann. N. Y. Acad. Sci., 1202, 79-86. DOI |
9 | Salehi, S., Saljooghi, A.S. and Shiri, A. (2016) Synthesis, characterization and in vitro anticancer evaluations of two novel derivatives of deferasirox iron chelator. Eur. J. Pharmacol., 781, 209-217. DOI |
10 | Ryu, H.W., Lee, D.H., Won, H., Kim, K.H., Seong, Y.J. and Kwon, S.H. (2015) Influence of toxicologically relevant metals on human epigenetic regulation. Toxicol. Res., 31, 1-9. DOI |
11 | Saljooghi, A.S. and Fatemi, S.J. (2010) Removal of thallium by deferasirox in rats as biological model. J. Appl. Toxicol., 31, 139-143. |
12 | Hoffman, R.S. (2003) Thallium toxicity and the role of Prussian blue in therapy. Toxicol. Rev., 22, 29-40. DOI |
13 | Voskaridou, E., Christoulas, D. and Terpos, E. (2011) Successful chelation therapy with the combination of deferasirox and deferiprone in a patient with thalassaemia major and persisting severe iron overload after single-agent chelation therapies. Br. J. Haematol., 154, 654-656. DOI |
14 | Harriss, W.R. and Messori, L. (2002) A comparative study of aluminum(III), gallium(III), indium(III), and thallium(III) binding to human serum transferrin. Coord. Chem. Rev., 228, 237-262. DOI |
15 | Saljooghi, A.S. and Fatemi, S.J. (2010) Clinical evaluation of Deferasirox for removal of cadmium ions in rat. Biometals, 23, 707-712. DOI |
16 | Balooch, F.D., Fatemi, S.J. and Iranmanesh, M. (2014) Combined chelation of lead (II) by deferasirox and deferiprone in rats as biological model. BioMetals, 27, 89-95. DOI |
17 | Fatemi, S.J., Saljooghi, A.S., Balooch, F.D., Iranmanesh, M. and Golbafan, M.R. (2011) Chelation of cadmium by combining deferasirox and deferiprone in rats. Toxicol. Ind. Health, 27, 371-377. DOI |
18 | Amiri, A., Fatemi, S.J. and Fatemi, S.N. (2007) Removal of thallium by combining desferrioxamine and deferiprone chelators in rats. Biometals, 20, 159-163. DOI |
19 | Tubafard, S. and Fatemi, S.J. (2008) Chelation of bismuth by combining desferrioxamine and deferiprone in rats. Toxicol. Ind. Health, 24, 235-240. DOI |
20 | Rodriguez-Mercado, J.J. and Altamirano-Lozano, M.A. (2013) Genetic toxicology of thallium: a review. Drug Chem. Toxicol., 36, 369-383. DOI |
21 | Xiao, T., Guha, J., Boyle, D., Liu, C.Q. and Chen, J. (2004) Environmental concerns related to high thallium levels in soils and thallium uptake by plants in southwest Guizhou, China. Sci. Total Environ., 318, 223-244. DOI |
22 | Peter, A.L. and Viraraghavan, T. (2005) Thallium: a review of public health and environmental concerns. Environ. Int., 3, 493-501. |
23 | Atlas, E., Fishbein, L., Giam, C.S., Leonard, J.E., Muir, D.C.G., Powers, M.A., Jr. and Schoer, J. (1984) Handbook of environmental chemistry; volume 3 part C. (Hutzinger, O. Ed.). Springer-Verlag, New York, pp. 143-214. |
24 | Abdel-Daim, M.M. and Abdou, R.H. (2015) Protective effects of diallyl sulfide and curcumin separately against thalliuminduced toxicity in rats. Cell J., 17, 379-388. |
25 | Riyaz, R., Pandalai, S.L., Schwartz, M. and Kazzi, Z.N. (2013) A fatal case of thallium toxicity: challenges in management. J. Med. Toxicol., 9, 75-78. DOI |
26 | Clarke, E.T. and Martell, A. E. (1992) Stabilities of 1,2-dimethyl-3-hydroxy-4-pyridinone chelates of divalent and trivalent metal ions. Inorg. Chim. Acta, 191, 57-63. DOI |
27 | Gomez, W., Esparza, J.L., Domingo, J.L., Corbella, J., Singh, P.K. and Jones, M.M. (1998) Aluminium distribution and excretion: a comparative study of a number of chelating agents in rats. Pharmacol. Toxicol., 82, 295-300. DOI |
28 | Lan, C.H. and Lin, T.S. (2005) Acute toxicity of trivalent thallium compounds to Daphnia magna. Ecotoxicol. Environ. Saf., 61, 432-435. DOI |
29 | Iranmanesh, M., Fatemi, S.J., Ebrahimpour, R. and Balooch, F.D. (2013) Chelation of chromium(VI) by combining Deferasirox and deferiprone in rats. Biometals, 26, 465-471. DOI |